Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Diagnostics Sector Q4 FY26 Outlook: Strong Revenue, Profit Growth Expected

Diagnostics Sector Q4 FY26 Outlook: Strong Revenue, Profit Growth Expected

The Indian diagnostics sector is poised for a robust performance in Q4FY26, with analysts forecasting significant revenue and profit growth, outshining its healthcare counterparts due to strong domestic demand and insulation from global geopolitical risks. Photograph: Ihsaan Haffejee/Reuters Key Points

New launches to keep growth momentum healthy for Sun Pharma stock

New launches to keep growth momentum healthy for Sun Pharma stock

Incremental gains for the company, and the listed pharma universe more broadly, also stemmed from positive sentiment around the India–US trade deal. About a third of Sun Pharma’s revenues come from the US market. Photograph: Francia Mascarenhas/Reuters Key Points The